Clinical Trial: A Study of BMS-986504 in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion

U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT06855771) titled 'A Study of BMS-986504 in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion' on Feb. 27.

Brief Summary: The purpose of this study is to evaluate the safety and efficacy of BMS-986504 monotherapy in participants with advanced or metastatic Non-small Cell Lung Cancer (NSCLC) with homozygous MTAP deletion after progression on prior therapies.

Study Start Date: May 30

Study Type: INTERVENTIONAL

Condition: Carcinoma, Non-Small-Cell Lung

Intervention: DRUG: BMS-986504

Specified dose on specified days

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Bristol-Myers Sq...